“Secukinumab’s Pooled and Long-Term Safety: Analysis of 19 Psoriasis Clinical Trials Up to 5 Years of Treatment”. 2018. SKIN The Journal of Cutaneous Medicine 2 (S1): S18. https://doi.org/10.25251/skin.2.supp.18.